What is the long term effect of 1550 nm erbium glass fractional laser in acne vulgaris?

Long-Term Impact of 1550 nm Erbium Glass Fractional Laser in Acne Vulgaris: Clinical Evidence Shows Sustained Benefits

Acne vulgaris, one of the most common chronic skin conditions, affects nearly 85% of adolescents and a significant number of adults worldwide. While traditional therapies such as topical retinoids, antibiotics, and systemic isotretinoin remain widely used, their limitations-including drug resistance, relapse rates, and side effects-have driven the search for safer, more effective alternatives. Recent studies now point to the 1550 nm erbium glass fractional laser as a promising long-term treatment option with clinically proven benefits.

Clinical Efficacy Backed by Long-Term Data

Multiple clinical trials have demonstrated the sustained efficacy of the 1550 nm fractional laser in patients with moderate to severe acne vulgaris. The treatment works by delivering precise microthermal zones into the dermis, triggering collagen remodeling, regulating sebaceous gland activity, and reducing inflammatory lesions.

Research outcomes have been particularly striking:

At six months post-treatment, the mean percent reduction in acne lesions reached 72%.

At the one-year follow-up, lesion reduction improved to 79%.

At the two-year follow-up, results remained stable, with a 75% overall reduction.

These findings indicate not only strong short-term improvement but also durable long-term control of acne activity, a key differentiator compared to conventional therapies that often require continuous maintenance.

Safety and Tolerability

One of the main concerns in laser dermatology is patient safety and tolerability. In these long-term studies, side effects were generally mild and temporary.

The most common adverse reactions were transient erythema (redness) and edema (swelling), both resolving within days.

A small number of patients experienced temporary acne flare-ups or heightened skin sensitivity, but these were self-limiting.

No long-term scarring or pigmentary complications were reported, underscoring the favorable safety profile of the device.

Advantages Over Traditional Therapies

Compared to long-term oral antibiotics or isotretinoin, the erbium glass fractional laser provides a drug-free solution, avoiding risks such as antibiotic resistance or systemic side effects. Furthermore, patient compliance is improved, as laser treatments typically require only several sessions rather than daily regimens.

According to Dr. Li Wei, a Beijing-based dermatologist involved in clinical evaluations:

"The 1550 nm erbium glass fractional laser has transformed acne treatment. We see not only a dramatic reduction in lesions but also long-lasting results that extend up to two years. Patients particularly appreciate the dual benefit-acne control and improvement in acne scars."

Future Outlook

As demand grows for non-invasive, effective, and durable treatments, the role of the 1550 nm erbium glass fractional laser in acne management is expected to expand. Ongoing studies are exploring its use in combination therapies, pairing laser treatment with topical agents or light-based modalities to maximize outcomes.

For patients and clinicians alike, the evidence is compelling: the 1550 nm erbium glass fractional laser offers a safe, clinically validated pathway toward long-term acne control and skin rejuvenation.

New Product Announcement

In response to this growing demand, Newangie has recently developed and launched its own 1550 nm erbium glass fractional laser machine. Designed to address a wide range of skin concerns-including acne, acne scars, and overall skin rejuvenation-this advanced system delivers safe, effective, and reliable results. We warmly welcome inquiries and pre-orders from clinics, beauty centers, and distributors worldwide.